Clarity Pharmaceuticals Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Other Revenue	10.58	9.46	11.51	9.8	6.46	3.2
Revenue	10.58	9.46	11.51	9.8	6.46	3.2
Revenue Growth (YoY)	-1.83%	-17.76%	17.41%	51.74%	102.07%	14.62%
Gross Profit	10.58	9.46	11.51	9.8	6.46	3.2
Selling, General & Admin	17.72	11.68	9.94	4.71	4.61	3.83
Research & Development	88.82	66.88	45.78	31.46	18.9	9.68
Operating Expenses	106.54	78.56	55.72	36.16	23.51	13.51
Operating Income	-95.96	-69.09	-44.21	-26.36	-17.05	-10.31
Interest & Investment Income	6.12	4.76	2.77	1.86	0.1	0.04
Currency Exchange Gain (Loss)	-5.68	0.45	-0.59	-	-	-
EBT Excluding Unusual Items	-95.52	-63.88	-42.03	-24.5	-16.95	-10.27
Other Unusual Items	-	-	-	-	-6.78	0.05
Pretax Income	-95.52	-63.88	-42.03	-24.5	-23.74	-10.22
Income Tax Expense	0.72	0.42	0.3	0.1	0.02	-
Net Income	-96.35	-64.3	-42.32	-24.6	-23.75	-10.22
Net Income to Common	-96.35	-64.3	-42.32	-24.6	-23.75	-10.22
Shares Outstanding (Basic)	343	319	273	260	248	176
Shares Outstanding (Diluted)	343	319	273	260	248	176
Shares Change (YoY)	13.88%	16.86%	5.22%	4.81%	40.37%	20.54%
EPS (Basic)	-0.28	-0.20	-0.15	-0.09	-0.10	-0.06
EPS (Diluted)	-0.28	-0.20	-0.15	-0.10	-0.10	-0.06
Free Cash Flow	-72.59	-54.95	-43.74	-27.55	-13.53	-7.74
Free Cash Flow Per Share	-0.21	-0.17	-0.16	-0.11	-0.06	-0.04
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-906.99%	-730.16%	-384.24%	-269.00%	-263.94%	-322.65%
Profit Margin	-910.66%	-679.45%	-367.82%	-251.03%	-367.78%	-319.77%
Free Cash Flow Margin	-686.15%	-580.71%	-380.14%	-281.07%	-209.43%	-242.06%
EBITDA	-95.71	-68.91	-44.06	-26.26	-17	-10.3
EBITDA Margin	-	-	-	-267.97%	-263.22%	-
D&A For EBITDA	0.25	0.19	0.15	0.1	0.05	0.02
EBIT	-95.96	-69.09	-44.21	-26.36	-17.05	-10.31
EBIT Margin	-	-	-	-269.00%	-263.94%	-
Revenue as Reported	13.77	14.68	14.28	11.66	6.55	3.29

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.